Impact Factor
4.70
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
12.84
2,632 total citations
h5-index
71
h5 depth signal
Cited share
93.1%
202 of 217
Total citations
2,632
Citation footprint
Metric signal
13.44
External metric anchor
Self-citation
1.1%
30 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United Kingdom
291
United States
237
France
185
Italy
183
Germany
142
Citing Fields of Research
Respiratory Support
283
Allergies
271
Lung Cancer
207
Auto-Inflammatory Disorders
177
Cystic Fibrosis
103
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,712
Articles tracked across the journal lifetime
Indexed publication set
217
202 cited publications
Last 12 months
155
38.8 publications/month
Open access share
100.0%
155 OA publications in the last year
Leading citing country
United Kingdom
291 citing publications
Leading citing field
Respiratory Support
283 citing publications
Latest tracked publication
7 October 2026
10 recent records available
Coverage & Indexing History
v19n115, Mar. 2010-
v19n115, Mar. 2010-
Active Coverage
Research Focus & Classification
Indexed Subjects
Respiratory Support
Allergies
Auto-Inflammatory Disorders
Lung Cancer
Cystic Fibrosis
Issuing & Sponsoring Bodies
Contributor
European Respiratory Society
Broad Categories
Pulmonary Medicine
Allergies
Cystic Fibrosis
Auto-Inflammatory Disorders
Virology
Respiratory Support
MeSH Descriptors
Respiratory Tract Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1183/16000617.0213-2026
Open DOI
The dipeptidyl peptidase 1 inhibition landscape in bronchiectasis and its future direction
Bronchiectasis (BE) is a heterogeneous lung disease characterised by chronic neutrophilic inflammation. A “vicious vortex” develops through the interactions between neutrophilic inflammation, infection and impaired mucociliary clearance,...
02
DOI 10.1183/16000617.0282-2025
Open DOI
Bridging bench and bedside: translational omics of Pseudomonas aeruginosa to validate physiologically relevant models of chronic respiratory infection in cystic fibrosis
While culturing the opportunistic pathogen Pseudomonas aeruginosa in standard bacterial culture media has provided fundamental insights into its pathological properties such as virulence and antibiotic resistance, growing evidence sugges...
03
DOI 10.1183/16000617.0205-2026
Open DOI
Inflammasomes in respiratory diseases: from disease pathogenesis to drug development and use of multi-omics
Inflammasomes are pivotal for the initiation and control of host inflammatory responses. This is particularly important in the respiratory system due to its direct exposure to noxious environmental and infectious stimuli, which can cause...
04
DOI 10.1183/16000617.0167-2026
Open DOI
Manual compared to automated closed-loop oxygen control strategies in hospitalised adults: a systematic review and meta-analysis
Background: Closed-loop oxygen control (CLOC) systems improve accuracy of oxygen delivery compared with standard manual oxygen adjustment. Determination of their efficacy in delivering oxygen noninvasively to adults, using different deli...
05
DOI 10.1183/16000617.0092-2026
Open DOI
Effects of opioids and stimulants on the respiratory system
Drug overdose remains an urgent public health concern as it is a leading cause of fatal injury in the United States, with approximately 90% being attributed to opioid-induced respiratory depression from synthetic opioids. This statistic ...
06
DOI 10.1183/16000617.0095-2026
Open DOI
Selective phosphodiesterase 4B inhibition in fibrotic lung disease: a scoping review of vascular–immune mechanisms and extrapulmonary implications
Background: Preferential phosphodiesterase 4B (PDE4B) inhibition with nerandomilast has demonstrated attenuation of forced vital capacity decline in idiopathic pulmonary fibrosis and progressive pulmonary fibrosis. Because PDE4 enzymes r...
07
DOI 10.1183/16000617.0069-2026
Open DOI
Change in pulmonary artery pressure upon acute exposure to high altitude: a systematic review and meta-analysis
Background/research question: We investigated the increase in pulmonary artery pressure (PAP) with altitude gain in healthy low-altitude residents travelling to high altitude, analysing reported measures including systolic (sPAP) and mea...
08
DOI 10.1183/16000617.0185-2026
Open DOI
Beyond nocturnal hypercapnia: positioning obstructive sleep apnoea within a sleep–circadian–hypothalamic network
Extract We read with great interest the comprehensive review by Randerath et al. [1] on nocturnal hypercapnia in obstructive sleep apnoea (OSA) and obesity hypoventilation syndrome (OHS). The authors elegantly highlighted that hypercapni...
09
DOI 10.1183/16000617.0036-2026
Open DOI
The triple-hit hypothesis: exploring pulmonary e-cigarette, PM 2.5 and viral polyexposure
Exposure to e-cigarette aerosols, particulate matter with aerodynamic diameter ≤2.5 µm (PM 2.5 ) and respiratory viruses rarely occurs in isolation, but rather in complex polyexposure contexts during daily life. On a cellular and molecul...
10
DOI 10.1183/16000617.0311-2025
Open DOI
Comparative response to pharmacological management of asthma in overweight/obese children versus their counterparts: a systematic review and call for data
Background: Obese children with asthma experience higher morbidity than their counterparts; whether different treatments should be considered remains to be clarified. Objective: To explore the potential group differences in the treatment...
Bibliographical & Catalog Notes
Title from analytical t.p.
Some issues have also a distinctive title.
Print issues ceased with v. 15, no. 101 (2006).
Also issued online.